Nova Patents
AP1905A

Pyrrolo[2,3-d] Pyrimidine Compounds.

Abstract

A compound of formula (I) wherein R1,R2 and R3 are as defined above, which are inhibitors of the enzyme protein kinases such as Janus Kinase 3 and as such are useful therapy as immunosuppressive agents for organ transplants, xeno transplantation, lupus, multiple scelerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, Leukemia and other autoimmune diseases.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

Every citation, both waysCites: the store holds 1 of 2

Citations
DocumentRelationOfficeCited during
EP0795556A1CitesEuropean Patent Office (EPO)Search report
J. of Med. Chem.; US Chem. Soc.; Vol.39, No.12Non-patentSearch report